This company has shut down. TeraImmune is no longer operating — its last tracked round was a Debt Financing in 2022.
Explore the Startup GraveyardTeraImmune is a developer of cell therapeutics created for autoimmune diseases and immune-related disorders.
TeraImmune has raised $3.0M in total funding. The most recent round was Debt Financing. The last funding was announced in December 2022.
TeraImmune's investors include Shinhan Venture Investment.
TeraImmune is headquartered in Gaithersburg, United States.
TeraImmune is a developer of cell therapeutics created for autoimmune diseases and immune-related disorders.
TeraImmune is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TeraImmune — Funding & Investors." VCBacked, December 22, 2022, https://www.vcbacked.co/company/teraimmune. Accessed August 14, 2026.
VCBacked. (2022). TeraImmune — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/teraimmune
{{cite web |title=TeraImmune — Funding & Investors |url=https://www.vcbacked.co/company/teraimmune |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated